Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Next Up For Cubist: A Future That Includes Optimer, Trius

Aug 26 2013

Related Content

Cubist Gets Entereg And A Late-Stage Compound With Adolor Buy

Oct 24 2011

Optimer's Early Sales Of Dificid Topping Analyst Projections

Nov 04 2011

Trius Antibiotic Tedizolid Hits Old, New And In-Between Endpoints

Apr 01 2013

Two New Sides Of Cubist: Antibiotics Maker Buys Both Optimer And Trius

Jul 31 2013

Optimer Is Up For Sale And Could Attract Hospital-Focused Suitors

Feb 27 2013

Related Companies

Cubist Pharmaceuticals, Inc.

Trius Therapeutics, Inc.

Astellas Pharma, Inc.

AstraZeneca PLC

ViroPharma Inc.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

The Medicines Company

Bayer AG

Additional Topics

Launches Deals BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window